Total AKT levels measured by Real Time PCR are reduced in Jurkat and T-ALL patient's lymphoblasts by both compounds (JWH-133 and RTX) (Figure 3A, 3B). The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.